In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Procept BioRobotics Corp (NASDAQ: PRCT) closed the day trading at $57.03 down -3.39% from the previous closing price of $59.03. In other words, the price has decreased by -$3.39 from its previous closing price. On the day, 0.93 million shares were traded. PRCT stock price reached its highest trading level at $58.8 during the session, while it also had its lowest trading level at $56.35.
Ratios:
For a better understanding of PRCT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.01 and its Current Ratio is at 9.07. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on December 02, 2024, initiated with a Overweight rating and assigned the stock a target price of $105.
On November 14, 2024, Jefferies started tracking the stock assigning a Hold rating and target price of $95.
On August 11, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $42.Piper Sandler initiated its Overweight rating on August 11, 2023, with a $42 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 18 ’25 when Zadno Reza bought 5,475 shares for $57.06 per share.
Waters Kevin bought 733 shares of PRCT for $41,825 on Mar 18 ’25. On Mar 18 ’25, another insider, Shiblaq Hisham, who serves as the Officer of the company, bought 247 shares for $57.06 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 3235950592 and an Enterprise Value of 2874835456. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.93 while its Price-to-Book (P/B) ratio in mrq is 7.76. Its current Enterprise Value per Revenue stands at 12.806 whereas that against EBITDA is -31.46.
Stock Price History:
The Beta on a monthly basis for PRCT is 1.08, which has changed by 0.17514944 over the last 52 weeks, in comparison to a change of 0.07465422 over the same period for the S&P500. Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $45.56. The 50-Day Moving Average of the stock is -17.92%, while the 200-Day Moving Average is calculated to be -23.49%.
Shares Statistics:
Over the past 3-months, PRCT traded about 897.79K shares per day on average, while over the past 10 days, PRCT traded about 925970 shares per day. A total of 54.72M shares are outstanding, with a floating share count of 51.87M. Insiders hold about 5.38% of the company’s shares, while institutions hold 92.02% stake in the company. Shares short for PRCT as of 1740700800 were 5079251 with a Short Ratio of 5.66, compared to 1738281600 on 5980863. Therefore, it implies a Short% of Shares Outstanding of 5079251 and a Short% of Float of 12.47.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
